- Home
- IKT vs CCRN Comparison
IKT vs CCRN Comparison
Compare IKT & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IKT | CCRN |
|---|---|---|
| Founded | 2008 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.1M | 270.9M |
| IPO Year | 2020 | 2001 |
Fundamental Metrics
Financial Performance| Metric | IKT | CCRN |
|---|---|---|
| Price | $1.85 | $9.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $5.50 | ★ $13.15 |
| AVG Volume (30 Days) | ★ 2.2M | 565.4K |
| Earning Date | 11-14-2025 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.51 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $816,484,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.93 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.33 | $7.43 |
| 52 Week High | $2.46 | $15.30 |
Technical Indicators
Market Signals| Indicator | IKT | CCRN |
|---|---|---|
| Relative Strength Index (RSI) | 48.12 | 54.51 |
| Support Level | $1.45 | $7.68 |
| Resistance Level | $2.10 | $9.40 |
| Average True Range (ATR) | 0.12 | 0.49 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 24.19 | 46.47 |
Price Performance
Historical ComparisonAbout IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.